Avanos Medical, Inc. (AVNS)
Avanos Medical, Inc., a medical technology company, focuses on delivering medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America.
It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions; and respiratory health products, such as closed airway suction systems and other airway management devices under the Ballard, Microcuff, and Endoclear brands.
The company also provides a portfolio of non-opioid pain solutions, including acute pain products, such as On-Q and ambIT surgical pain pumps, Game Ready cold, and compression therapy systems; and interventional pain solutions, which offers minimally invasive pain-relieving therapies, such as Coolief pain relief therapy.
It markets its products directly to hospitals and other healthcare providers, healthcare facilities, and other end-user customers, as well as through third-party wholesale distributors.
The company was formerly known as Halyard Health, Inc. and changed its name to Avanos Medical, Inc. in June 2018.
Avanos Medical, Inc. was incorporated in 2014 and is headquartered in Alpharetta, Georgia.
5405 Windward Parkway, Suite 100 South
Alpharetta, Georgia 30004
|Fiscal Year||January - December|
|Joseph F. Woody||Chief Executive Officer and Director|
|Michael C. Greiner||Senior Vice President, Chief Financial Officer and Principal Accounting Officer|
|David Edward Ball||Senior Vice President of Global Supply Chain and Procurement|
|William David Haydon||Senior Vice President and GM of Pain Management|
|Kerr W. Holbrook||Senior Vice President and GM of Chronic Care|
|David Crawford||Vice President of FP&A and Investor Relations and Treasurer|
|Michelle Scharfenberg||Senior Vice President and Chief Ethics and Compliance Officer|
|Mojirade James||Senior Vice President, General Counsel and Corporate Secretary|
|Scott Galovan||Vice President of Strategy and Corporate Development|
|Arjun Ranjan Sarker||Senior Vice President of International|
Latest SEC Filings
|Mar 17, 2023||ARS||Filing|
|Mar 17, 2023||DEFA14A||Additional definitive proxy soliciting materials and Rule 14(a)(12) material|
|Mar 17, 2023||DEF 14A||Other definitive proxy statements|
|Mar 6, 2023||8-K||Current Report|
|Feb 21, 2023||10-K||Annual Report|
|Feb 21, 2023||8-K/A||[Amend] Current report|
|Feb 21, 2023||8-K||Current Report|
|Feb 17, 2023||8-K||Current Report|
|Feb 13, 2023||SC 13G/A||[Amend] Statement of acquisition of beneficial ownership by individuals|
|Feb 10, 2023||SC 13G||Statement of acquisition of beneficial ownership by individuals|